RiboTargets is a privately owned pharmaceutical drug discovery company focused on the development of novel anti-bacterial and anti-cancer therapeutics. These therapeutic areas represent significant market opportunities. The Company has created and validated a proprietary structure-based drug discovery engine that allows the rapid identification and optimisation of drug candidates against both protein and nucleic acid targets using high throughput computer-aided and experimental drug design. Over the last four years, RiboTargets has made the transition from a technology platform company into a competitive drug discovery company. RiboTargets' goal for 2003 is to make the pivotal step from research into formal drug development. In the longer term, RiboTargets aims to become a significant player in the anti-bacterial and anti-cancer markets.
| Website | http://ribotargets.com |
| Employees | View employees |
| Address | PO Box 9008, Farmingdale, New York 11735, US |
| Industry | Consumer Services General, Consumer Services |
| Competitors | MGB Biopharma Limited, Lakewood-Amedex Inc., SCYNEXIS, Inc., Genoscience Pharma, NewBiotics (view competitors) |
| SIC | SIC Code 73 Companies, SIC Code 732 Companies |
| NAICS | NAICS Code 561 Companies, NAICS Code 56 Companies |
Looking for a particular RiboTargets employee's phone or email?
RiboTargets Questions
RiboTargets is based in Farmingdale, New York.
The NAICS codes for RiboTargets are [561, 56].
The SIC codes for RiboTargets are [73, 732].
